NY A08130 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Republican 22-0)
Status: Introduced on October 13 2023 - 25% progression
Action: 2024-05-14 - held for consideration in health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Sponsors


Roll Calls

2024-05-14 - Assembly - Assembly Health Committee: Held for Consideration (Y: 17 N: 7 NV: 0 Abs: 2) [PASS]

History

DateChamberAction
2024-05-14Assemblyheld for consideration in health
2024-01-03Assemblyreferred to health
2023-10-13Assemblyreferred to health

Same As/Similar To

S07753 (Same As) 2024-01-03 - REFERRED TO HEALTH

New York State Sources


Bill Comments

feedback